%0 Generic
%T Overcoming the proliferation rate paradox: Clinical evaluation of a continuous dosing scheme of the novel oral Eg5 inhibitor 4SC-205.
%A Mross, Klaus B.
%A Scharr, Dirk
%A Richly, Heike
%A Bauer, Sebastian
%A Krauss, Babett
%A Krauss, Rolf
%A Hauns, Bernhard
%A Prenzel, Tanja
%A Kohlhof, Hella
%A Baumgartner, Roland
%A Scheulen, Max E.
%I American Society of Clinical Oncology (ASCO)
%@ 0732-183X
%@ 1527-7755
%K Cancer Research
%K Oncology
%D 2015
%C American Society of Clinical Oncology (ASCO)
%U http://slubdd.de/katalog?TN_libero_mab2
Download citation